Corey Davis | LifeSci Advisors |
Glenn Mattes | President, CEO & Director |
Dale Christensen | Head, Clinical Development |
Kirk Coleman | CFO, Treasurer & Secretary |
Robert Williams | Technology Inventor & Special Advisor |
Jonathan Aschoff | ROTH Capital Partners |
Vernon Bernardino | H.C. Wainwright & Co. |
Michael Okunewitch | Maxim Group |
Greetings, and welcome to the TFF Pharmaceuticals, Inc.
Third Quarter 2022 Earnings Conference Call. [Operator Instructions]. It is now my pleasure to introduce Corey Davis. Thank you, and you may proceed.